Please assess the completion status of the following clinical trial:

Trial Title: Assessing Suicide Risk in Adolescents With Developmental Delays

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~Client must be enrolled in individual counseling at the Surrey Center at time of participation and must have attended at least 3 therapy appointments.~Clients must have an IQ score betwen 55 and 75 (a range considered to mild developmental delay). A client with mild DD will have the ability to communicate verbally and provide writtent assent. In order to receive services at Surrey Place Centre, clients must have a designation of developmental delay with and IQ score or range. If they do not have an IQ Score or DD designation, they undergo assessment at intake. Therefore, each client will have an IQ score recorded prior to study recruitment.~Age 12 years or older~English speaking~A legal guardian must provide informed consent and client must sign an assent document. Verbal assent is not acceptable for participation.~EXCLUSION CRITERIA:~Legal guradian is non-English speaking and no translation support is available to assist with the consent process.~No IQ score on record.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).